Breaking News, Promotions & Moves

Cedarburg Hauser Appoints Process Development Director

Tretyakov to lead process and analytical development groups

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Alex Tretyakov, Ph.D. has been appointed director of process development at Cedarburg Hauser Pharmaceuticals (CHP). Dr. Tretyakov will lead the company’s process and analytical development groups, and will join chief scientific officer John Lynch, in providing technical insight into customer projects.   Most recently, Dr. Tretyakov served as vice president of R&D at PCI Synthesis and Cambridge Major Laboratories.   “In his 25-plus years of industry experience Alex has demonstrate...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters